{"id":"W3155566811","doi":"10.1016/j.arrct.2021.100123","title":"Phase IIB Randomized Trial on the Use of 4-Aminopyridine in Guillain-Barré Syndrome","year":2021,"lang":"en","type":"article","venue":"Archives of Rehabilitation Research and Clinical Translation","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Food and Drug Administration; U.S. Food and Drug Administration","keywords":"Medicine; Physical therapy; Randomized controlled trial; Placebo; Physical medicine and rehabilitation; Surgery","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high","status":"direct model label, unvalidated"}],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002105489,0.001678208,0.003376319,0.0004183861,0.0004980675,0.001099606,0.001022165,0.002832135,0.009338313],"category_scores_gemma":[0.002500612,0.0007782988,0.001235842,0.0004568904,0.0009359033,0.0009332387,0.0003307182,0.002855495,0.001504205],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006988788,"about_ca_system_score_gemma":0.00126053,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001133493,"about_ca_topic_score_gemma":0.002118625,"domain_scores_codex":[0.9990747,0.0005824752,0.00005983661,0.0001088413,0.00005153414,0.0001225647],"domain_scores_gemma":[0.9988382,0.0003948233,0.0002986186,0.00008411942,0.00009023974,0.0002939996],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9832313,0.003537439,0.0003324244,0.0005693621,0.0003687412,0.00003416406,0.00003074042,0.0001427622,0.001424422,0.0000740959,0.0006231142,0.009631348],"study_design_scores_gemma":[0.9773048,0.02153011,0.0005199641,0.00002195345,0.00009442498,0.00001195232,0.000008133055,0.000119223,0.0000929803,0.0000362902,0.0002566059,0.000003621378],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9641534,0.009958418,0.001451116,0.001672568,0.001702474,0.014243,0.001988066,0.0003346578,0.004496243],"genre_scores_gemma":[0.9678457,0.005288212,0.002574772,0.002454299,0.00101491,0.015115,0.001487885,0.00003623821,0.004182971],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009338313,"threshold_uncertainty_score":0.03123981,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1987072062623221,"score_gpt":0.4523032135257067,"score_spread":0.2535960072633847,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}